| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/20/2011 | US8021665 Identification and application of antibiotic synergy |
| 09/20/2011 | US8021664 Improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy |
| 09/20/2011 | US8021662 Microorganisms for therapy |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | US8021645 Clostridium difficile associated diseases; gastrointestinal tract degradation resistance |
| 09/20/2011 | CA2545470C Streptococcus phocae vaccine |
| 09/20/2011 | CA2536632C Therapy-enhancing glucan |
| 09/20/2011 | CA2482512C Improved viral purification methods |
| 09/20/2011 | CA2476477C Tissue specific expression |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2426348C Retrovirus isolated from humans |
| 09/20/2011 | CA2416519C Transportation of nucleic acid substances |
| 09/20/2011 | CA2412075C Attenuated bovine respiratory syncytial virus |
| 09/20/2011 | CA2400562C Hybrid expression of neisserial proteins |
| 09/20/2011 | CA2399832C Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2369848C Human endogenous retrovirus in breast cancer |
| 09/20/2011 | CA2356009C Vascular endothelial growth factor-x |
| 09/20/2011 | CA2354475C Blends of isoflavones and flavones |
| 09/20/2011 | CA2337100C Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same |
| 09/20/2011 | CA2331258C Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220 |
| 09/20/2011 | CA2329137C Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer |
| 09/20/2011 | CA2217522C Isolated frpb nucleic acid molecule and vaccine |
| 09/17/2011 | CA2697804A1 System and process for producing multi-component biopharmaceuticals |
| 09/15/2011 | WO2011113056A1 Methods for preventing and treating staphylococcus aureus colonization, infection, and disease |
| 09/15/2011 | WO2011113041A2 Neutralization of flt3 ligand as a leukemia therapy |
| 09/15/2011 | WO2011112983A2 Psrp is a protective antigen against pneumococcal infection |
| 09/15/2011 | WO2011112978A1 Cd37-binding molecules and immunoconjugates thereof |
| 09/15/2011 | WO2011112955A1 Bluetongue virus recombinant vaccines and uses thereof |
| 09/15/2011 | WO2011112954A1 Inhibition of p21 and use thereof for inducing tissue regeneration |
| 09/15/2011 | WO2011112953A2 Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 09/15/2011 | WO2011112945A2 Foot and mouth disease virus recombinant vaccines and uses thereof |
| 09/15/2011 | WO2011112915A2 Methods and compositions containing fc fusiong proteins for enhancing immune responses |
| 09/15/2011 | WO2011112873A2 Extracorporeal immunoadsorption treatment |
| 09/15/2011 | WO2011112871A1 Vaccines for pandemic influenza |
| 09/15/2011 | WO2011112859A2 Methods relating to olanzapine pharmacogenetics |
| 09/15/2011 | WO2011112850A2 Humanized and chimeric anti-properdin antibodies |
| 09/15/2011 | WO2011112788A1 Methods of treating allergies with substantially phenol-free carriers |
| 09/15/2011 | WO2011112747A1 Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening |
| 09/15/2011 | WO2011112717A1 A novel mucosal vaccination approach for herpes simplex virus type-2 |
| 09/15/2011 | WO2011112670A2 Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease |
| 09/15/2011 | WO2011112599A2 Immunogenic pote peptides and methods of use |
| 09/15/2011 | WO2011112593A1 Method for protecting against disease caused by secondary pathogens |
| 09/15/2011 | WO2011112566A2 Basigin binding proteins |
| 09/15/2011 | WO2011112549A2 Temperature sensitive conjugate compositions, and uses related thereto |
| 09/15/2011 | WO2011112156A1 Anti-cancer agent delivery vehicles capable of improved laoding |
| 09/15/2011 | WO2011111898A1 Method for preparing mycobacterial cell wall skeleton |
| 09/15/2011 | WO2011111698A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 09/15/2011 | WO2011111694A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 09/15/2011 | WO2011111007A2 ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING |
| 09/15/2011 | WO2011110683A2 Glce as a target for anti-tumour therapy |
| 09/15/2011 | WO2011110642A2 Monoclonal antibodies against c-met |
| 09/15/2011 | WO2011110636A1 Immunogenic composition |
| 09/15/2011 | WO2011110635A1 Immunogenic composition |
| 09/15/2011 | WO2011110634A1 Vaccine composition |
| 09/15/2011 | WO2011110570A1 Treatment of streptococcal infections |
| 09/15/2011 | WO2011110546A2 Pharmaceutical composition comprising an inhibitor of shp-2 and screening method |
| 09/15/2011 | WO2011110241A1 Immunogenic composition comprising s. pneumoniae polysaccharides conjugated to carrier proteins |
| 09/15/2011 | WO2011080765A3 Recombinant human bivalent diabody against rabies virus and uses thereof |
| 09/15/2011 | WO2011080396A3 Probiotic bifidobacterial composition in accordance with secretor blood group status |
| 09/15/2011 | WO2011080395A3 Probiotic bifidobacterial composition in accordance with secretor blood group status |
| 09/15/2011 | WO2011057224A3 Zwitterionic polymer bioconjugates and related methods |
| 09/15/2011 | WO2011050431A3 Dna vaccine against virus of yellow fever |
| 09/15/2011 | WO2011050071A3 Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography |
| 09/15/2011 | WO2011034582A3 Hiv-1 antibodies |
| 09/15/2011 | WO2010104749A8 Antigen presenting cell targeted cancer vaccines |
| 09/15/2011 | WO2010031883A8 Immunotherapeutic agent suitable for the primary prophylaxis of tuberculosis |
| 09/15/2011 | US20110225660 Orally administrable immunostimulant product for aquaculture |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110223658 Monoclonal antibodies with enhanced adcc function |
| 09/15/2011 | US20110223645 Multivalent Carriers of Bi-Specific Antibodies |
| 09/15/2011 | US20110223242 Nanoparticles containing a peptide, vectors containing said nanoparticles, and pharmaceutical uses of said nanoparticles and vectors |
| 09/15/2011 | US20110223230 Hydrogel formulations |
| 09/15/2011 | US20110223217 Block copolymers and uses thereof |
| 09/15/2011 | US20110223208 Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
| 09/15/2011 | US20110223203 Nanocluster compositions and methods |
| 09/15/2011 | US20110223201 Immunonanotherapeutics Providing a Th1-Biased Response |
| 09/15/2011 | US20110223200 Novel compositions and methods |
| 09/15/2011 | US20110223199 METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
| 09/15/2011 | US20110223198 dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants |
| 09/15/2011 | US20110223197 Mucosal and Systemic Immunization with Alphavirus Replicon Particles |
| 09/15/2011 | US20110223196 Hiv/siv vaccines for the generation of mucosal and systemic immunity |
| 09/15/2011 | US20110223195 Composition comprising chitosan for ocular administration of vaccine(s) to avians |
| 09/15/2011 | US20110223194 Vaccine |
| 09/15/2011 | US20110223189 Agent for treating leishmania infections |
| 09/15/2011 | US20110223188 Targeted costimulatory polypeptides and methods of use to treat cancer |
| 09/15/2011 | US20110223187 Live listeria-based vaccines for central nervous system therapy |
| 09/15/2011 | US20110223186 Clostridium toxin, and process for the preparation of immunogenic composition |
| 09/15/2011 | US20110223185 Chimeric hepatitis c virus antigens for eliciting an immune response |
| 09/15/2011 | US20110223184 Dkk2 protein and use thereof |
| 09/15/2011 | US20110223183 Human notch3 based fusion proteins as decoy inhibitors of notch3 signaling |
| 09/15/2011 | US20110223182 Monoclonal antibodies for treatment of cancer |
| 09/15/2011 | US20110223181 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 09/15/2011 | US20110223180 Methods and compositions related to a multi-methylation assay to predict patient outcome |
| 09/15/2011 | US20110223179 Methods and compositions for malaria prophylaxis |
| 09/15/2011 | US20110223178 Antibodies That Specifically Bind to Chemokine Beta-4 |
| 09/15/2011 | US20110223177 Treatment of fibrotic eye disorders |
| 09/15/2011 | US20110223176 Basigin binding proteins |
| 09/15/2011 | US20110223175 Gene Encoding G-Protein Coupled Receptor And Gene Product Thereof |